Australia is closely watching the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor medication , representing a potential advance in obesity treatment . Early clinical trials have demonstrated https://joanipdk290743.blogzet.com/emerging-medication-in-australia-a-potential-hope-for-weight-loss-58958938